MARKET

NBIX

NBIX

Neurocrine Biosciences Inc
NASDAQ
152.72
+1.90
+1.26%
After Hours: 154.56 +1.84 +1.20% 19:57 08/14 EDT
OPEN
149.72
PREV CLOSE
150.82
HIGH
153.42
LOW
148.78
VOLUME
1.31M
TURNOVER
--
52 WEEK HIGH
186.12
52 WEEK LOW
122.14
MARKET CAP
15.52B
P/E (TTM)
22.39
1D
5D
1M
3M
1Y
5Y
1D
Balanced View on Neurocrine: Vykat XR Safety Overhang, Tempered Ingrezza Growth, and Price Target Raised to $190
TipRanks · 1d ago
Neurocrine Is Maintained at Equal-Weight by Morgan Stanley
Dow Jones · 1d ago
Neurocrine Price Target Cut to $182.00/Share From $196.00 by Morgan Stanley
Dow Jones · 1d ago
Morgan Stanley Maintains Equal-Weight on Neurocrine Biosciences, Lowers Price Target to $182
Benzinga · 1d ago
Analysts’ Top Healthcare Picks: Neurocrine (NBIX), Aquestive Therapeutics (AQST)
TipRanks · 2d ago
Morgan Stanley Remains a Hold on Neurocrine (NBIX)
TipRanks · 2d ago
Deutsche Bank Sticks to Its Hold Rating for Neurocrine (NBIX)
TipRanks · 2d ago
What's Going On With Neurocrine Biosciences Stock On Wednesday?
Benzinga · 2d ago
More
About NBIX
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. It is engaged in discovering, developing, and commercializing life-changing treatments for patients with under-addressed neurological, psychiatric, endocrine, and immunological disorders. Its diverse portfolio includes the United States Food and Drug Administration-approved treatments for tardive dyskinesia, chorea associated with Huntington’s disease, endometriosis and uterine fibroids, as well as a robust pipeline, including multiple compounds in mid-to late-phase clinical development across its core therapeutic areas. Its first-in-class commercial portfolio includes INGREZZA (valbenazine) and CRENESSITY (crinecerfont). It also offers VYKAT XR (diazoxide choline) extended-release tablets, for the treatment of hyperphagia in adults and pediatric patients four years of age and older with Prader-Willi syndrome (PWS). Its pipeline includes direclidine / (M4 Agonist), osavampator॥ / (AMPA PAM) and others.

Webull offers Neurocrine Biosciences, Inc stock information, including NASDAQ: NBIX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NBIX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NBIX stock methods without spending real money on the virtual paper trading platform.